Development of a synthetic cyclized peptide derived from α‐fetoprotein that prevents the growth of human breast cancer
- 1 September 2001
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 58 (3), 246-256
- https://doi.org/10.1034/j.1399-3011.2001.00922.x
Abstract
The peptide, EMTPVNPG, derived from alpha‐fetoprotein, inhibits estrogen‐stimulated growth of immature mouse uterus and estrogen‐dependent proliferation of human breast cancer cells. Howeve...This publication has 30 references indexed in Scilit:
- Cyclic and linear bradykinin analogues: implications for B2antagonist designChemical Biology & Drug Design, 1999
- Solid‐state chemical stability of proteins and peptidesJournal of Pharmaceutical Sciences, 1999
- Aggregation of Recombinant Human Interferon Gamma: Kinetics and Structural TransitionsJournal of Pharmaceutical Sciences, 1998
- Rigidity of Human α-Fetoprotein Tertiary Structure Is under Ligand ControlBiochemistry, 1997
- Constitution of a biphasic insulin response to glucose in human fetal pancreatic beta-cells with glucagon-like peptide 1Journal of Clinical Endocrinology & Metabolism, 1995
- Interfacial Adsorption and Aggregation Associated Changes in Secondary Structure of Human Calcitonin Monitored by ATR-FTIR SpectroscopyBiochemistry, 1994
- Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptidesJournal of Molecular Biology, 1992
- Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's diseaseJournal of Molecular Biology, 1991
- Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic .beta.-protein fragmentsBiochemistry, 1990
- Stability of human interferon-ß1: oligomeric human interferon-ß1 is inactive but is reactivated by monomerizationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989